Browse All

Current Filters

CLEAR FILTER x

TITLE

An Investigator Initiated Study of KYV-101, a CD19 CAR T Cell Therapy, in Participants with Treatment Refractory Progressive Multiple Sclerosis

Author:Gupta, Sasha   Seshadri, Madhav   Lincoln, Robin   Okinishi, Naomi   Shum, Nancy   Shenoy, Samantha   Wilmoth, Jenai   Hauser, Stephen   Cree, Bruce   

Session Name:S3: Multiple Sclerosis: Clinical Trials  

Topic:Multiple Sclerosis  

Program Number:S3.002  

Author Institution:University of California, San Francisco, San Francisco, CA  University of California San Francisco, San Francisco, CA  

Enhanced Safety Profile of Ocrelizumab Over Rituximab in Multiple Sclerosis Treatment

Author:Cerono, Gabriel   Cree, Bruce   Hauser, Stephen   Baranzini, Sergio   

Session Name:P8: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 2  

Topic:Multiple Sclerosis  

Program Number:P8.006  

Author Institution:UCSF, San Francisco, CA  UCSF, Multiple Sclerosis Center, San Francisco, CA  UCSF Weill Institute for Neurosciences, San Francisco, CA